financetom
Business
financetom
/
Business
/
US drops appeal in case over UnitedHealth Medicare plans' rating
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US drops appeal in case over UnitedHealth Medicare plans' rating
Jan 24, 2025 11:52 AM

Jan 24 (Reuters) - The U.S. Centers for Medicare and

Medicaid Services on Friday said it would not appeal a court

order that it recalculate the public star ratings it gave to

UnitedHealth's ( UNH ) privately administered Medicare health

insurance plans, which the insurer said would cost it millions

of dollars from lost customers.

The agency did not give a reason for withdrawing the notice

of appeal it had filed just three days earlier. It was not clear

whether the move was part of a broader policy change by

President Donald Trump's new administration.

CMS declined to comment, citing a pause on public

communications by health agencies ordered by the Trump

administration. UnitedHealth ( UNH ) did not immediately respond to a

request for comment.

The lawsuit concerns UnitedHealth's ( UNH ) Medicare Advantage

plans, which are privately administered health insurance plans

funded by the federal Medicare program for those age 65 and

older and some Americans with disabilities.

CMS assigns Medicare Advantage plans ratings of one to five

stars to help consumers choose among plans. UnitedHealth ( UNH ) said in

its lawsuit that some of its Medicare Advantage plans lost half

a star because of a single unsuccessful call placed by a CMS

test caller seeking a foreign language interpreter.

UnitedHealth ( UNH ) said that CMS was arbitrary and capricious in

docking the star ratings on the basis of a single call, and said

that an error by the test caller was responsible for failing to

connect with a representative.

A Texas federal judge in November agreed and ordered CMS to

recalculate the star rating.

Other insurers, including Elevance, Centene ( CNC )

and Humana, have also sued CMS over what they allege are

unfair star ratings.

CMS previously recalculated star ratings for Elevance and

non-profit SCAN Health Plans' Medicare Advantage plans after

losing court rulings.

UnitedHealth Group ( UNH ) shares were up about 0.6% at $532.86.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Michelin shares fall as much as 11% after profit warning
Michelin shares fall as much as 11% after profit warning
Oct 14, 2025
PARIS (Reuters) -Shares in Michelin fell as much as 11% on Tuesday, to their lowest in almost three years, after the tire maker cut its forecast for full-year income more than expected due to weak business conditions in North America. The company said late on Monday it expected 2025 segment operating income of between 2.6 billion euros and 3.0 billion...
Lithia & Driveway (LAD) Expands Retail Network in Southeast Region
Lithia & Driveway (LAD) Expands Retail Network in Southeast Region
Oct 14, 2025
MEDFORD, Ore., Oct. 14, 2025 /PRNewswire/ -- Lithia & Driveway today announced the acquisition of Stivers Decatur Subaru in the Atlanta market. This strategic move increases network density in the Southeast region and strengthens LAD's import mix, bringing in an estimated $100 million in annualized revenue. We are pleased to welcome Stivers Decatur Subaru to the Lithia & Driveway family. The...
US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership
US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership
Oct 14, 2025
Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical ( TAK ), deepening their use of artificial intelligence to accelerate drug discovery. Under the new multi-year agreement, which builds on an earlier collaboration launched in 2022, Nabla will receive upfront and research cost payments...
Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities
Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities
Oct 14, 2025
SAN DIEGO, Oct. 14, 2025 /PRNewswire/ -- Cortechs.ai, a leader in AI-driven neuroimaging software, today announces the acquisition of intellectual property from ZepMed, LLC, including its patented CT imaging technologies and flagship product, NeuroAlign CT™. This strategic acquisition strengthens Cortechs.ai's position at the forefront of radiological innovation and expands its suite of best-in-class solutions for clinicians worldwide.  With this acquisition,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved